Cost-Effectiveness Analysis of Methods of Diagnosis of Tb Infection in Russian Regions by Use of Recombinant Tb Allergen in Children and Adolescents

• Autorzy: Malwina Holownia , Ilya Solodun , Ekaterina Bashlakova , Tatiana Ermolaeva , Maria Davydovskaya , Evgeniy Evdoshenko
• Języki publikacji: EN

Abstrakty

EN

Background. Russia is among the countries with a high burden of TB. A new diagnostic method for TB has been developed, called 'recombinant tuberculosis allergen' or RTA (Diaskintest®), which has a similar cost and method of administration to the Mantoux test, but the principle of action, sensitivity and specificity are similar to IGRA technology. Despite the improvements of RTA, TB experts continue to use the Mantoux test. The aim of this study was to determine the most cost-effective medical technology for diagnosing tuberculosis infection in the Russian Federation, basing on calculation of ICER. Methods. The study was based on 3 models simulating the diagnosis of TB in Russia: 1-Mantoux test and further diagnostics methods (based on screening in 2008 in 1,302,490 Moscow children and adolescents); 2-Mantoux test with subsequent use of RTA in case of a positive Mantoux test, combined with further diagnostics methods (based on screening in 2013 in 1,420,100 Moscow children and adolescents); 3-RTA alone and further diagnostics methods (data based on screening conducted in 2015 in 108,729 Penza region children and adolescents 8-17 y.o.). Results. Method effectiveness (percentage of active TB infection among screened individuals), was 0.006%, 0.012% and 0.019% for models 1, 2 and 3, respectively. Cost-effectiveness ratios were 41861.67, 18401.67 and 10512.12 for models 1, 2 and 3, respectively. Conclusions. RTA is the most cost-effective tuberculosis screening method in children and adolescents, superior to both the stand-alone Mantoux test or the Mantoux test followed by RTA. (original abstract)

Słowa kluczowe

EN

Illness; Medical treatment

PL

Choroby; Leczenie

• Czasopismo: Journal of Health Policy and Outcomes Research
• Rocznik: 2017
• Numer: nr 2
• Strony: 40--45

Twórcy

autor

Malwina Holownia

• State Budgetary Institution

autor

Ilya Solodun

• State Budgetary Institution

autor

Ekaterina Bashlakova

• State Budgetary Institution

autor

Tatiana Ermolaeva

• State Budgetary Institution

autor

Maria Davydovskaya

• State Budgetary Institution

autor

Evgeniy Evdoshenko

• State Budgetary Institution

Bibliografia

• Electronic resource URL: "World Health Organization Tuberculosis - fact sheet" N°104, March 2015 [cited: 11.12.2015]. Available from: http://who.int/mediacentre/factsheets/fs104/ru/.
• Russian Ministry of Health Order № 951 of December 29, 2014 "On approval of recommendations for improving the diagnosis and treatment of pulmonary tuberculosis."
• Mack U., Migliori G., Sester M., et al. for TBNETCONSENSUS STATEMENT LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J 2009; N. 33; 956-973.
• Electronic resource URL: http://grls.rosminzdrav.ru. [cited: 11.12.2015]
• Electronic resource URL: http://zakupki.gov.ru. [cited: 25.01.2016]
• Slogotskaya L.V., Ovsyankina E.S., Kochetkov, Y.A. Stakheyeva L.B. Infection with tuberculosis of children and adolescents - a look through the century.Tuberculosis and lung diseases 2011; N. 3; 21-28.
• Slogotskaya L.V., Senchikhina O.Y., Nikitina G.V., Bogorodskaya E.M. The effectiveness of recombinant tuberculosis allergen skin test in detecting tuberculosis in children and adolescents in Moscow in 2013. Pediatric pharmacology 2015; Vol 12; N. 1 ; 1-5.
• Stasko Е.Y., Khasashin G.S. Analysis of the use of skin testing with recombinant tuberculosis allergen as a screening method of screening for tuberculosis children older than 7 years in the Penza region. Tuberculosis and lung diseases; 2016; N. 3 ; 1-5.
• Yagudina R.I., Zinchuk I.Y. Pharmacoeconomic study of drugs used for TB screening. Pharmacoeconomics; 2013; Vol. 6, N. 1.

Identyfikatory

DOI

10.7365/JHPOR.2018.1.5